UNLEASHING THE TRUTH ABOUT DIABETES ANDHEART DISEASE Trademark

Trademark Overview


On Wednesday, March 20, 2019, a trademark application was filed for UNLEASHING THE TRUTH ABOUT DIABETES ANDHEART DISEASE with the United States Patent and Trademark Office. The USPTO has given the UNLEASHING THE TRUTH ABOUT DIABETES ANDHEART DISEASE trademark a serial number of 88349105. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The UNLEASHING THE TRUTH ABOUT DIABETES ANDHEART DISEASE trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting public awareness of diabetes and heart disease and their symptoms, prevention and treatment

Providing medical information on diabetes and heart disease and their symptoms, prevention and treatment; providing medical information about treatment for type 2 diabetes and cardiovascular disease through videos

Providing online videos featuring information about treatment for type 2 diabetes and cardiovascular disease, not downloadable; providing a website featuring non-downloadable videos in the field of treatment for type 2 diabetes and cardiovascular disease
unleashing the truth about diabetes andheart disease

General Information


Serial Number88349105
Word MarkUNLEASHING THE TRUTH ABOUT DIABETES ANDHEART DISEASE
Filing DateWednesday, March 20, 2019
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6240428
Registration DateTuesday, January 5, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements


Goods and ServicesPromoting public awareness of diabetes and heart disease and their symptoms, prevention and treatment
Goods and ServicesProviding medical information on diabetes and heart disease and their symptoms, prevention and treatment; providing medical information about treatment for type 2 diabetes and cardiovascular disease through videos
Description of MarkThe mark consists of the wording "UNLEASHING THE TRUTH ABOUT DIABETES + HEART DISEASE" in stylized form, with "unleashing" depicted in red and the remainder in blue, with a design comprising a blue leash in the shape of a heart affixed to the "g" in "unleashing".
Goods and ServicesProviding online videos featuring information about treatment for type 2 diabetes and cardiovascular disease, not downloadable; providing a website featuring non-downloadable videos in the field of treatment for type 2 diabetes and cardiovascular disease
Indication of Colors claimedThe color(s) red and blue is/are claimed as a feature of the mark.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 8, 2019
Primary Code035
First Use Anywhere DateTuesday, June 30, 2020
First Use In Commerce DateTuesday, June 30, 2020

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, August 19, 2019
Primary Code041
First Use Anywhere DateTuesday, June 30, 2020
First Use In Commerce DateTuesday, June 30, 2020

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 19, 2019
Primary Code044
First Use Anywhere DateTuesday, June 30, 2020
First Use In Commerce DateTuesday, June 30, 2020

Trademark Owner History


Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events


Event DateEvent Description
Saturday, March 23, 2019NEW APPLICATION ENTERED
Monday, April 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 15, 2019ASSIGNED TO EXAMINER
Monday, April 15, 2019NON-FINAL ACTION WRITTEN
Monday, April 15, 2019NON-FINAL ACTION E-MAILED
Monday, April 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 28, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 28, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, August 28, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 28, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, August 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 5, 2019ASSIGNED TO LIE
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 11, 2020SOU TEAS EXTENSION RECEIVED
Monday, May 11, 2020SOU EXTENSION 1 FILED
Monday, May 11, 2020SOU EXTENSION 1 GRANTED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 20, 2020TEAS STATEMENT OF USE RECEIVED
Monday, November 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 20, 2020USE AMENDMENT FILED
Monday, November 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 2, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 3, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED